30
Participants
Start Date
August 31, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
March 31, 2010
AS1411
AS1411 40 mg/kg/day) will be administered on days 1-4 via a continuous iv infusion every 28-day cycle for up to 2 cycles
Medical University of South Carolina, Charleston
James Graham Brown Cancer Center, University of Louisville, Louisville
St Francis Hospital, Beech Grove
City of Hope, Duarte
University of California San Francisco, San Francisco
University of California, Davis Cancer Center, Sacramento
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston
Lead Sponsor
Antisoma Research
INDUSTRY